Latest Breaking News On - Teva proair - Page 1 : comparemela.com

Intech Biopharm Corp (益得生技) has started testing the effects of a metered-dose inhaler generic of Teva Pharmaceutical Industries Ltd’s ProAir, and expects to gain marketing approval by 2023, it said yesterday. The company, which developed SYN011 to treat acute asthma, received approval from the US Food and Drug Administration in August to study the biochemical and physiological effects of the drug in a phase 3 clinical trial, Intech spokesperson Hugues Hung (洪堯國) told the Taipei Times. The company has recruited about 200 participants with asthma for the test, dividing them into control and experiment groups to receive a placebo, a brand name

T ai peiTeva proairPeter linCipla ltdIntech biopharm corpMerck sharp dohme ltdTaipei exchange onTaipei timesLupin ltdTeva pharmaceutical industries ltd proairKao shih chingBiopharm corpTeva pharmaceutical industries ltdDrug administrationHugues hungTaipei exchange